Prevalence and Determinants of Fatigue after COVID-19 in Non-Hospitalized Subjects: A Population-Based Study.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
19 02 2021
Historique:
received: 27 12 2020
revised: 31 01 2021
accepted: 16 02 2021
entrez: 6 3 2021
pubmed: 7 3 2021
medline: 13 3 2021
Statut: epublish

Résumé

This study assessed the prevalence and determinants of fatigue in a population-based cohort of non-hospitalized subjects 1.5-6 months after COVID-19. It was a mixed postal/web survey of all non-hospitalized patients ≥18 years with a positive PCR for SARS-CoV-2 until 1 June 2020 in a geographically defined area. In total, 938 subjects received a questionnaire including the Chalder fatigue scale (CFQ-11) and the energy/fatigue scale of the RAND-36 questionnaire. We estimated z scores for comparison with general population norms. Determinants were analyzed using multivariable logistic and linear regression analysis. In total, 458 subjects (49%) responded to the survey at median 117.5 days after COVID-19 onset, and 46% reported fatigue. The mean z scores of the CFQ-11 total was 0.70 (95% CI 0.58 to 0.82), CFQ-11 physical 0.66 (0.55 to 0.78), CFQ-11 mental 0.47 (0.35 to 0.59) and RAND-36 energy/fatigue -0.20 (-0.31 to -0.1); all CFQ-11 scores differed from those of the norm population (

Identifiants

pubmed: 33669714
pii: ijerph18042030
doi: 10.3390/ijerph18042030
pmc: PMC7921928
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Arch Intern Med. 2007 Jun 25;167(12):1312-20
pubmed: 17592106
QJM. 2020 Sep 1;113(9):657-665
pubmed: 32442308
Cad Saude Publica. 2020 Apr 30;36(4):e00054020
pubmed: 32374806
Psychiatry Res. 2020 Nov;293:113382
pubmed: 32829073
BMJ. 1990 Nov 24;301(6762):1199-202
pubmed: 2261560
Int J Public Health. 2018 Jul;63(6):765-773
pubmed: 29691594
Lancet Infect Dis. 2020 Oct;20(10):1115-1117
pubmed: 32888409
Am J Public Health. 2016 Aug;106(8):1422-6
pubmed: 27196650
Ann Epidemiol. 2007 Sep;17(9):643-53
pubmed: 17553702
J Psychosom Res. 1993;37(2):147-53
pubmed: 8463991
BMJ. 2006 Sep 16;333(7568):575
pubmed: 16950834
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998
pubmed: 32730238
J Psychosom Res. 1998 Jul;45(1):53-65
pubmed: 9720855
PLoS One. 2020 Nov 9;15(11):e0240784
pubmed: 33166287
Arch Intern Med. 2009 Dec 14;169(22):2142-7
pubmed: 20008700
J Med Virol. 2021 Feb;93(2):1013-1022
pubmed: 32729939
MMWR Morb Mortal Wkly Rep. 2020 Jul 17;69(28):904-908
pubmed: 32673296
BMJ. 2020 Jul 14;370:m2815
pubmed: 32665317
J Pain Symptom Manage. 2009 Jan;37(1):107-28
pubmed: 19111779
BMJ. 1994 Mar 19;308(6931):763-6
pubmed: 7908238
Recenti Prog Med. 2020 Dec;111(12):788-789
pubmed: 33362178
Arch Public Health. 2020 May 25;78:46
pubmed: 32509303
Qual Life Res. 2006 Mar;15(2):217-31
pubmed: 16468078
New Sci. 2020 Apr 18;246(3278):10-11
pubmed: 32372811
Med Care. 1996 Jan;34(1):73-84
pubmed: 8551813
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Thorax. 2020 Dec 3;:
pubmed: 33273028
Health Econ. 1993 Oct;2(3):217-27
pubmed: 8275167
BMC Public Health. 2020 Jun 23;20(1):988
pubmed: 32576168
Clin Infect Dis. 2020 Nov 21;:
pubmed: 33220049
J Rehabil Med. 2020 May 25;52(5):jrm00063
pubmed: 32449782
Nature. 2020 Sep;585(7825):339-341
pubmed: 32929257
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
Support Care Cancer. 2011 Aug;19(8):1255-9
pubmed: 21479788
Can Fam Physician. 1987 May;33:1217-9
pubmed: 21263931
Psychiatry Investig. 2019 Jan;16(1):59-64
pubmed: 30605995
Br J Health Psychol. 2020 Nov;25(4):875-882
pubmed: 32458550
J Gen Intern Med. 1997 Jul;12(7):423-30
pubmed: 9229281
Brain Sci. 2020 Dec 19;10(12):
pubmed: 33352638
Health Qual Life Outcomes. 2017 Mar 14;15(1):51
pubmed: 28292292
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Clin Infect Dis. 2020 Nov 30;:
pubmed: 33252665
Clin Med (Lond). 2021 Jan;21(1):e68-e70
pubmed: 33144403
J Korean Med Sci. 2020 Dec 07;35(47):e418
pubmed: 33289374
BMJ Open. 2016 Jan 06;6(1):e009912
pubmed: 26739738
ERJ Open Res. 2020 Oct 26;6(4):
pubmed: 33257910
J Trauma Stress. 2020 Aug;33(4):365-370
pubmed: 32662129
BMJ. 2020 May 22;369:m1985
pubmed: 32444460

Auteurs

Knut Stavem (K)

Institute of Clinical Medicine, University of Oslo, 0450 Oslo, Norway.
Health Services Research Unit, Akershus University Hospital, 1478 Lørenskog, Norway.
Department of Pulmonary Medicine, Division of Medicine, Akershus University Hospital, 1478 Lørenskog, Norway.

Waleed Ghanima (W)

Institute of Clinical Medicine, University of Oslo, 0450 Oslo, Norway.
Department of Medicine, Østfold Hospital Trust, 1714 Grålum, Norway.
Department of Research, Østfold Hospital Trust, 1714 Grålum, Norway.

Magnus K Olsen (MK)

Department of Research, Østfold Hospital Trust, 1714 Grålum, Norway.

Hanne M Gilboe (HM)

Fürst Medical Laboratory, 1051 Oslo, Norway.

Gunnar Einvik (G)

Institute of Clinical Medicine, University of Oslo, 0450 Oslo, Norway.
Department of Pulmonary Medicine, Division of Medicine, Akershus University Hospital, 1478 Lørenskog, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH